OGESTREL 0.5/50-21 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ogestrel 0.5/50-21, and what generic alternatives are available?
Ogestrel 0.5/50-21 is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in OGESTREL 0.5/50-21 is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for OGESTREL 0.5/50-21
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 339 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OGESTREL 0.5/50-21 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OGESTREL 0.5/50-21
US Patents and Regulatory Information for OGESTREL 0.5/50-21
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | OGESTREL 0.5/50-21 | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 075406-001 | Dec 15, 1999 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |